IntriCon to be acquired by Altaris Capital affiliate for $241M

• Intricon (NASDAQ:IIN) has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry, will acquire the company.
• Under the terms, Altaris will acquire all outstanding shares of Intricon for $24.25/share in a transaction that values Intricon at an equity value of ~$241M.
• The purchase price represents a meaningful premium of ~39% to Intricon’s closing stock price on Feb. 25, 2022.
• The transaction is expected to close in Q2 2022.